litlas
Log inCreate account

Joshua M. Hare

Active 1992–2025

Also published as
Joshua M Hare
209
Papers
47,143
Citations
115
h-index
206
i10-index

Citations

Citations per year for Joshua M. Hare1971: 1 citations1986: 1 citations1992: 2 citations1993: 1 citations1994: 2 citations1995: 11 citations1996: 16 citations1997: 31 citations1998: 34 citations1999: 61 citations2000: 68 citations2001: 84 citations2002: 123 citations2003: 176 citations2004: 203 citations2005: 269 citations2006: 329 citations2007: 319 citations2008: 327 citations2009: 330 citations2010: 379 citations2011: 441 citations2012: 491 citations2013: 485 citations2014: 443 citations2015: 445 citations2016: 447 citations2017: 403 citations2018: 505 citations2019: 1,259 citations2020: 1,407 citations2021: 1,608 citations2022: 1,191 citations2023: 862 citations2024: 1,215 citations2025: 536 citations2026: 12 citations1972–1985: no citations, so these years are not shown1987–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,429 citing papers, 27.2% of this breakdownChina: 1,714 citing papers, 10.5% of this breakdownGermany: 994 citing papers, 6.1% of this breakdownItaly: 942 citing papers, 5.8% of this breakdownUnited Kingdom: 937 citing papers, 5.7% of this breakdownCanada: 541 citing papers, 3.3% of this breakdownJapan: 500 citing papers, 3.1% of this breakdownFrance: 476 citing papers, 2.9% of this breakdownNetherlands: 456 citing papers, 2.8% of this breakdownSpain: 367 citing papers, 2.2% of this breakdownAustralia: 316 citing papers, 1.9% of this breakdownSwitzerland: 291 citing papers, 1.8% of this breakdown
0%27.2%Other 26.7%

Institutions

Fields

  • Medicine71.2%
  • Biochemistry, Genetics and Molecular Biology20.5%
  • Engineering2.1%
  • Neuroscience2%
  • Immunology and Microbiology1.5%
  • Materials Science1.1%
  • Other1.6%

Topics

  • Mesenchymal stem cell research6.3%
  • Tissue Engineering and Regenerative Medicine5.1%
  • Nitric Oxide and Endothelin Effects2.6%
  • Viral Infections and Immunology Research2.4%
  • Cardiovascular Function and Risk Factors2.4%
  • Extracellular vesicles in disease2.4%
  • Other78.8%

Coauthors

All papers

Open in search
  1. Mesenchymal stem cell perspective: cell biology to clinical progress

    Authors: Mark F. Pittenger, Dennis E. Discher, Bruno Péault, Donald G. Phinney, Joshua M. Hare, Arnold I. Caplan - npj Regenerative Medicine 2019 cited by 2,016

  2. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

    Authors: Carsten Tschöpe, Enrico Ammirati, Biykem Bozkurt, Alida L.P. Caforio, Leslie T. Cooper, Stephan B. Felix, Joshua M. Hare, Bettina Heidecker, Stéphane Heymans, Norbert Hübner, Sebastian Kelle, Karin Klingel, Henrike Maatz, Abdul Shokor Parwani, Frank Spillmann, Randall C. Starling, Hiroyuki Tsutsui, Petar Seferović, Sophie Van Linthout - Nature Reviews Cardiology 2020 cited by 1,183

  3. FGF23 induces left ventricular hypertrophy

    Authors: Christian Faul, Ansel P. Amaral, Behzad N. Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mündel, Azorides R. Morales, Julia J. Scialla, Michael J. Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal A. Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro‐o, John W. Kusek, Martin Keane, Myles Wolf - Journal of Clinical Investigation 2011 cited by 1,999

  4. Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy

    Authors: Joshua M. Hare, Joel E. Fishman, Gary Gerstenblith, Darcy L. Velazquez, Juan P. Zambrano, Viky Y. Suncion, Melissa Tracy, Eduard Ghersin, Peter V. Johnston, Jeffrey Brinker, Elayne Breton, Janice Davis‐Sproul, John Byrnes, Richard T. De George, Albert C. Lardo, Ivonne Hernandez Schulman, Adam Mendizabal, Maureen H. Lowery, Didier Rouy, Peter Altman, Cheryl Wong Po Foo, Phillip Ruiz, Alexandra Amador, Jose Da Silva, Ian McNiece, Alan W. Heldman - JAMA 2012 cited by 1,178

  5. Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

    Authors: Bettina Heidecker, Noa Dagan, Ran D. Balicer, Urs Eriksson, Giuseppe Rosano, Andrew J.S. Coats, Carsten Tschöpe, Sebastian Kelle, Gregory A. Poland, Andrea Frustaci, Karin Klingel, Pilar Martı́n, Joshua M. Hare, Leslie T. Cooper, Antonis Pantazis, Massimo Imazio, Sanjay Prasad, Thomas F. Lüscher - European Journal of Heart Failure 2022 cited by 152

  6. Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges

    Authors: Luiza Bagno, Konstantinos E. Hatzistergos, Wayne Balkan, Joshua M. Hare - Molecular Therapy 2018 cited by 342

  7. Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

    Authors: G. Michael Felker, Richard E. Thompson, Joshua M. Hare, Ralph H. Hruban, Diedre E. Clemetson, David L. Howard, Kenneth L. Baughman, Edward K. Kasper - New England Journal of Medicine 2000 cited by 1,719

  8. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications

    Authors: Cristine E. Berry, Joshua M. Hare - The Journal of Physiology 2003 cited by 928

  9. Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics

    Authors: Joel A. Mintz, Anastasia Vedenko, Omar Rosete, Khushi Shah, Gabriella Goldstein, Joshua M. Hare, Ranjith Ramasamy, Himanshu Arora - Vaccines 2021 cited by 175

  10. Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy

    Authors: Alan W. Heldman, Darcy L. DiFede, Joel E. Fishman, Juan P. Zambrano, Barry Trachtenberg, Vasileios Karantalis, Muzammil Mushtaq, Adam Williams, Viky Y. Suncion, Ian McNiece, Eduard Ghersin, Victor Soto, Gustavo Lopera, Roberto Miki, Howard J. Willens, Robert C. Hendel, Raul D. Mitrani, Pradip M. Pattany, Gary Feigenbaum, Behzad N. Oskouei, John Byrnes, Maureen H. Lowery, Julio Sierra, M Pujol, Cindy Delgado, Phillip Gonzalez, Jose Rodriguez, Luiza Bagno, Didier Rouy, Peter Altman, Cheryl Wong Po Foo, Jose Da Silva, Erica Anderson, Richard P. Schwarz, Adam Mendizabal, Joshua M. Hare - JAMA 2013 cited by 561

  11. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy

    Authors: Alexander Grabner, Ansel P. Amaral, Karla Schramm, Saurav Singh, Alexis Sloan, Christopher Yanucil, Jihe Li, Lina A. Shehadeh, Joshua M. Hare, Valentin David, Aline Martin, Alessia Fornoni, Giovana Seno Di Marco, Dominik Kentrup, Stefan Reuter, Anna B. Mayer, Hermann Pavenstädt, Jörg Stypmann, Christian Kühn, Susanne Hille, Norbert Frey, Maren Leifheit‐Nestler, Beatrice Richter, Dieter Haffner, Reimar Abraham, Johannes Bange, Bianca Sperl, Axel Ullrich, Marcus Brand, Myles Wolf, Christian Faul - Cell Metabolism 2015 cited by 532

  12. Challenges in developing Geroscience trials

    Authors: Yves Rolland, Felipe Sierra, Luigi Ferrucci, Nir Barzilai, Rafael de Cabo, Joan B. Mannick, Anthony A. Oliva, William J. Evans, Davide Angioni, Philipe de Souto Barreto, Jérémy Raffin, Bruno Vellas, James L. Kirkland, the G.C.T-TF group, Sandrine Andrieu, Daniel Bacqueville, Heike A. Bischoff‐Ferrari, Guillaume Blivet, Timothy P. Cash, Ana-Maria Cuervo, Noélie Davezac, Andrea Dimet‐Wiley, Alexander Fleming, Friedlander Gérard, Mitzi M. Gonzales, Sophie Guyonnet, Joshua M. Hare, Suzanne Hendrix, Christian Jørgensen, Matt Kaeberlein, Mehmood Khan, Stephen B. Kritchevsky, Aksana Labokha, Olivier Lairez, Stephanie Lederman, Jean Mariani, Lefkos Middleton, John Newman, Angelo Parini, Susan Peschin, Marco Prunotto, Sami Sagol, Suzanne M. Tomlinson, Georg C. Terstappen, Jacques Touchon, Cendrine Tourette, Rob van Maanen, Eric Verdin, Stan Watowich, Lei Zhang, Alex Zhavoronkov - Nature Communications 2023 cited by 79

  13. Inflammatory Cardiomyopathic Syndromes

    Authors: Barry Trachtenberg, Joshua M. Hare - Circulation Research 2017 cited by 291

  14. A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

    Authors: Joshua M. Hare, Jay H. Traverse, Timothy D. Henry, Nabil Dib, Robert K. Strumpf, Steven P. Schulman, Gary Gerstenblith, Anthony N. DeMaria, Ali E. Denktas, Roger Gammon, James Hermiller, Mark Reisman, Gary L. Schaer, Warren Sherman - Journal of the American College of Cardiology 2009 cited by 1,348

  15. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue

    Authors: Samuel Golpanian, Ariel Wolf, Konstantinos E. Hatzistergos, Joshua M. Hare - Physiological Reviews 2016 cited by 359

  16. A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial

    Authors: Roberto Bolli, Raul D. Mitrani, Joshua M. Hare, Carl J. Pepine, Emerson C. Perin, James T. Willerson, Jay H. Traverse, Timothy D. Henry, Phillip C. Yang, Michael P. Murphy, Keith L. March, Ivonne Hernandez Schulman, Sohail Ikram, David P. Lee, Connor O’Brien, João A.C. Lima, Mohammad R. Ostovaneh, Bharath Ambale‐Venkatesh, Gregory D. Lewis, Aisha Khan, Ketty Bacallao, Krystalenia Valasaki, Bangon Longsomboon, Adrian P. Gee, Sara Richman, Doris A. Taylor, Dejian Lai, Shelly L. Sayre, Judy Bettencourt, Rachel W. Vojvodic, Michelle Cohen, Lara M. Simpson, David Aguilar, Cătălin Loghin, Lem Moyé, Ray F. Ebert, Barry R. Davis, Robert D. Simari - European Journal of Heart Failure 2021 cited by 166

  17. Therapeutic Perspectives for Inflammation and Senescence in Osteoarthritis Using Mesenchymal Stem Cells, Mesenchymal Stem Cell-Derived Extracellular Vesicles and Senolytic Agents

    Authors: Michael G. Rizzo, Thomas M. Best, Johnny Huard, Marc J. Philippon, Francis J. Hornicek, Zhenfeng Duan, Anthony J. Griswold, Lee D. Kaplan, Joshua M. Hare, Dimitrios Kouroupis - Cells 2023 cited by 41

  18. Cardiomyocyte Regeneration: A Consensus Statement.

    Authors: Thomas Eschenhagen, Roberto Bolli, Thomas Braun, Loren J. Field, Bernd K. Fleischmann, Jonas Frisén, Mauro Giacca, Joshua M. Hare, Steven R. Houser, Richard Lee, Eduardo Marbán, James F. Martin, Jeffery D. Molkentin, Charles E. Murry, Paul R. Riley, Pilar Ruiz‐Lozano, Hesham A. Sadek, Mark A. Sussman, Joseph A. Hill - Circulation 2017 cited by 498

  19. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER)

    Authors: Marilyn K. Glassberg, Julia Minkiewicz, Rebecca L. Toonkel, Emmanuelle S. Simonet, Gustavo A. Rubio, Darcy L. DiFede, Shirin Shafazand, Aisha Khan, Marietsy V. Pujol, Vincent F. LaRussa, Lisa Lancaster, Glenn D. Rosen, Joel E. Fishman, Yolanda Mageto, Adam Mendizabal, Joshua M. Hare - CHEST Journal 2016 cited by 249

  20. Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method

    Authors: Luiza Bagno, Alessandro G. Salerno, Wayne Balkan, Joshua M. Hare - Expert Opinion on Biological Therapy 2021 cited by 72

  21. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)

    Authors: Victoria Florea, Angela C. Rieger, Darcy L. DiFede, Jill El-Khorazaty, Makoto Natsumeda, Monisha N. Banerjee, Bryon A. Tompkins, Aisha Khan, Ivonne Hernandez Schulman, Ana Marie Landin, Muzammil Mushtaq, Samuel Golpanian, Maureen H. Lowery, John Byrnes, Robert C. Hendel, Mauricio G. Cohen, Krystalenia Valasaki, Marietsy V. Pujol, Eduard Ghersin, Roberto Miki, Cindy Delgado, Fouad Abuzeid, Mayra Vidro-Casiano, Russell Saltzman, Daniel DaFonseca, Lina V. Caceres, Kevin Ramdas, Adam Mendizabal, Alan W. Heldman, Raul D. Mitrani, Joshua M. Hare - Circulation Research 2017 cited by 202

  22. Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    Authors: Bryon A. Tompkins, Darcy L. DiFede, Aisha Khan, Ana Marie Landin, Ivonne Hernandez Schulman, Marietsy V. Pujol, Alan W. Heldman, Roberto Miki, Pascal J. Goldschmidt‐Clermont, Bradley J. Goldstein, Muzammil Mushtaq, Silvina Levis-Dusseau, John Byrnes, Maureen H. Lowery, Makoto Natsumeda, Cindy Delgado, Russell Saltzman, Mayra Vidro-Casiano, Moisaniel Da Fonseca, Samuel Golpanian, Courtney Premer, Audrey Medina, Krystalenia Valasaki, Victoria Florea, Erica Anderson, Jill El-Khorazaty, Adam Mendizabal, Geoff Green, Anthony A. Oliva, Joshua M. Hare - The Journals of Gerontology Series A 2017 cited by 160

  23. Mesenchymal Stem Cells

    Authors: Adam Williams, Joshua M. Hare - Circulation Research 2011 cited by 898

  24. Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease

    Authors: Vasileios Karantalis, Joshua M. Hare - Circulation Research 2015 cited by 424